MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.

Lisheng Zhang,Lixin Yang,Xiyong Liu,Wei Chen,Lufen Chang,Linling Chen,Sofia Loera,Peiguo Chu,Wei-Chien Huang,Yun-Ru Liu,Yun Yen
DOI: https://doi.org/10.1002/hep.26162
IF: 17.298
2013-01-01
Hepatology
Abstract:Growing evidence indicates that deregulation of microRNAs (miRNAs) contributes to tumorigenesis. Dysregulation of miR-657 has been observed in several types of cancers, but its biological function is still largely unknown. Our results showed that miR-657 expression can be induced by hepatitis viral proteins and is significantly increased in hepatocellular carcinoma (HCC) tissues. Moreover, introduction of miR-657 dramatically increases proliferation and colony formation of HCC cells in vitro and induces tumor development in immunodeficient mice. Further studies showed that miR-657 directly targets the transducin-like enhancer protein 1 (TLE1) 3 ' untranslated region (UTR) and activates nuclear factor kappa B (NF-kappa B) pathways that contribute to hepatocarcinogenesis. Conclusion: This study identified a mechanism whereby miRNA-657 contributed to HCC through novel cancer pathways and provides new insights into the potential molecular mechanisms of hepatic carcinogenesis. (HEPATOLOGY 2013;57:1919-1930)
What problem does this paper attempt to address?